Your browser doesn't support javascript.
loading
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors.
Edwards, A Cole; Stalnecker, Clint A; Jean Morales, Alexis; Taylor, Khalilah E; Klomp, Jennifer E; Klomp, Jeffrey A; Waters, Andrew M; Sudhakar, Niranjan; Hallin, Jill; Tang, Tracy T; Olson, Peter; Post, Leonard; Christensen, James G; Cox, Adrienne D; Der, Channing J.
Afiliação
  • Edwards AC; Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Stalnecker CA; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Jean Morales A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Taylor KE; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Klomp JE; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Klomp JA; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Waters AM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Sudhakar N; Mirati Therapeutics, Inc., San Diego, California.
  • Hallin J; Mirati Therapeutics, Inc., San Diego, California.
  • Tang TT; Vivace Therapeutics, Inc., San Mateo, California.
  • Olson P; Mirati Therapeutics, Inc., San Diego, California.
  • Post L; Vivace Therapeutics, Inc., San Mateo, California.
  • Christensen JG; Mirati Therapeutics, Inc., San Diego, California.
  • Cox AD; Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Der CJ; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Cancer Res ; 83(24): 4112-4129, 2023 12 15.
Article em En | MEDLINE | ID: mdl-37934103

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Fatores de Transcrição de Domínio TEA / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Fatores de Transcrição de Domínio TEA / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article